CORC

在结果中检索

CORC

浏览/检索结果: 共24条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Altered brain metabolism and connectivity in temporal lobe epilepsy: an F-18-FDG PET study 会议论文
作者:  Guan, Yihui;  Huang, Qi;  Ren, ShuHua;  Jiang, Donglang;  Xie, Fang
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
Altered Brain Metabolism and Connectivity in Somatoform Disorders: an F-18-FDG PET Study 会议论文
作者:  Huang, Qi;  Jiang, Donglang;  Hua, Fengchun;  Ren, Shuhua;  Xie, Fang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Changes ofregional cerebral glucose metabolism in morphine-induced conditioned place preference rats 会议论文
作者:  Jiang, Donglang;  Shao, Da;  Huang, Qi;  Ren, Shuhua;  Guan, Yihui
收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
作者:  Qin, Yejun;  Liu, Jianping;  Li, Daiqiang;  Wang, Guoping;  Nie, Xiu
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace